## **Core Concept**
Factitious hyperinsulinemia and insulinoma are two conditions that can present with similar clinical and biochemical features, including hypoglycemia and elevated insulin levels. The key to differentiating between them lies in understanding the underlying cause of the hyperinsulinemia. Factitious hyperinsulinemia is caused by the exogenous administration of insulin, whereas insulinoma is a tumor of the pancreas that autonomously secretes insulin.

## **Why the Correct Answer is Right**
The correct answer, , involves measuring the **C-peptide** level. In insulinoma, both insulin and C-peptide levels are elevated because the tumor secretes proinsulin, which is then converted to insulin and C-peptide. In contrast, factitious hyperinsulinemia caused by exogenous insulin administration leads to elevated insulin levels but **low C-peptide levels** because exogenous insulin does not contain C-peptide. This difference makes C-peptide measurement a valuable tool in differentiating between the two conditions.

## **Why Each Wrong Option is Incorrect**
* **Option A:** Measuring blood glucose levels alone cannot differentiate between factitious hyperinsulinemia and insulinoma, as both conditions present with hypoglycemia.
* **Option B:** Proinsulin levels can be elevated in insulinoma but are not typically used as a first-line method to differentiate between the two conditions.
* **Option D:** Insulin antibody levels are not directly relevant to differentiating between factitious hyperinsulinemia and insulinoma.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that factitious hyperinsulinemia often has a **high insulin-to-C-peptide ratio**, whereas insulinoma has a **normal or low insulin-to-C-peptide ratio**. This distinction is critical in the evaluation of hypoglycemia with elevated insulin levels.

## **Correct Answer: C. C-peptide.**